TY - JOUR
T1 - Adult severe asthma registries
T2 - a global and growing inventory
AU - Cushen, Breda
AU - Koh, Mariko Siyue
AU - Tran, Trung N
AU - Martin, Neil
AU - Murray, Ruth B
AU - Uthaman, Thendral
AU - Goh, Yun Yi Celine
AU - Vella, Rebecca
AU - Eleangovan, Nevaashni
AU - Bulathsinhala, Lakmini
AU - Maspero, Jorge F
AU - Peters, Matthew J
AU - Schleich, Florence
AU - Pitrez, Paulo M
AU - Christoff, George
AU - Sadsatsafavi, Mohsen
AU - Torres-Duque, Carlos A.
AU - Porsbjerg, Celeste
AU - Altraja, Alan
AU - Lehtimäki, Lauri
AU - Bourdin, Arnaud
AU - Taube, Christian
AU - Papadopoulos, Nikolaos G
AU - Zsuzsanna, Csoma
AU - Björnsdóttir, Unnur S.
AU - Salvi, Sundeep
AU - Heffler, Enrico
AU - Iwanaga, Takashi
AU - Al-Ahmad, Mona
AU - Larenas-Linnemann, Désirée
AU - van Boven, Job FM
AU - Bøgvald Aarli, Bernt
AU - Kuna, Piotr
AU - Loureiro, Claudia Chaves
AU - Al-Lehebi, Riyad
AU - Lee, Jae Ha
AU - Marina, Nuria
AU - Bjermer, Leif
AU - Sheu, Chau-Chyun
AU - Sheu, Chau-Chyun
AU - Busby, John
AU - Wang, Eileen
AU - Price, David
N1 - Acknowledgement
The authors would like to thank Mr Joash Tan (BSc, Hons) and Ms Andrea Lim (BSc, Hons) of the Observational Pragmatic Research Institute (OPRI) for their editorial and formatting assistance that supported the development of this publication.
The author would also like to acknowledge the collaborators from the following countries, for their valuable contribution to the publication.
Funding statement
This study was conducted by the Observational and Pragmatic Research Institute (OPRI) Pte Ltd and was funded by Optimum Patient Care Global. No funding was received by the Observational & Pragmatic Research Institute Pte Ltd (OPRI) for its contribution
PY - 2023/10/20
Y1 - 2023/10/20
N2 - Aim: The International Severe Asthma Registry (ISAR; http://isaregistries.org/) uses standardised variables to enable multi-country and adequately powered research in severe asthma. This study aims to look at the data countries within ISAR and non-ISAR countries reported collecting that enable global research that support individual country interests.Methods: Registries were identified by online searches and approaching severe asthma experts. Participating registries provided data collection specifications or confirmed variables collected. Core variables (results from ISAR’s Delphi study), steroid-related comorbidity variables, biologic safety variables (serious infection, anaphylaxis, and cancer), COVID-19 variables and additional variables (notbelonging to the aforementioned categories) that registries reported collecting were summarised.Results: Of the 37 registries identified, 26 were ISAR affiliates and 11 non-ISAR affiliates. Twenty-five ISAR-registries and 4 non-ISAR registries reported collecting >90% of the 65 core variables. Twentythree registries reported collecting all optional steroid-related comorbidity variables. Twenty-nineregistries reported collecting all optional safety variables. Ten registries reported collecting COVID-19 variables. Twenty-four registries reported collecting additional variables including data from asthma questionnaires (10 Asthma Control Questionnaire, 20 Asthma Control Test, 11 Asthma Quality of LifeQuestionnaire, and 4 EuroQol 5-dimension 5-level Questionnaire). Eight registries are linked to databases such as electronic medical records and national claims or disease databases. Conclusion: Standardised data collection has enabled individual severe asthma registries to collect unified data and increase statistical power for severe asthma research irrespective of ISAR affiliations.
AB - Aim: The International Severe Asthma Registry (ISAR; http://isaregistries.org/) uses standardised variables to enable multi-country and adequately powered research in severe asthma. This study aims to look at the data countries within ISAR and non-ISAR countries reported collecting that enable global research that support individual country interests.Methods: Registries were identified by online searches and approaching severe asthma experts. Participating registries provided data collection specifications or confirmed variables collected. Core variables (results from ISAR’s Delphi study), steroid-related comorbidity variables, biologic safety variables (serious infection, anaphylaxis, and cancer), COVID-19 variables and additional variables (notbelonging to the aforementioned categories) that registries reported collecting were summarised.Results: Of the 37 registries identified, 26 were ISAR affiliates and 11 non-ISAR affiliates. Twenty-five ISAR-registries and 4 non-ISAR registries reported collecting >90% of the 65 core variables. Twentythree registries reported collecting all optional steroid-related comorbidity variables. Twenty-nineregistries reported collecting all optional safety variables. Ten registries reported collecting COVID-19 variables. Twenty-four registries reported collecting additional variables including data from asthma questionnaires (10 Asthma Control Questionnaire, 20 Asthma Control Test, 11 Asthma Quality of LifeQuestionnaire, and 4 EuroQol 5-dimension 5-level Questionnaire). Eight registries are linked to databases such as electronic medical records and national claims or disease databases. Conclusion: Standardised data collection has enabled individual severe asthma registries to collect unified data and increase statistical power for severe asthma research irrespective of ISAR affiliations.
KW - Asia-Pacific
KW - Biologics
KW - COVID-19
KW - Europe
KW - ISAR
KW - International Severe Asthma Registry
KW - Oral Corticosteroids
KW - Registry
KW - Middle East
KW - Severe Asthma
KW - Latin America
KW - USA
U2 - 10.2147/POR.S399879
DO - 10.2147/POR.S399879
M3 - Article
C2 - 37881411
SN - 1179-7266
VL - 2023
SP - 127—147
JO - Pragmatic and Observational Research
JF - Pragmatic and Observational Research
IS - 14
ER -